GBHI 2024: Join us in shaping the future of bioequivalence!

News of January 18th, 2024

We’re excited to announce that the stage is set for the 6th International Workshop – GBHI 2024 by PQRI/EUFEPS Global Bioequivalence Harmonisation Initiative. We at SocraTec R&D are proud to be at the forefront of bioequivalence expertise, especially in the field of modified release products:

  • Transdermal therapeutic systems
  • Long-acting injectables
  • Orally inhaled drug products

We’re proud to highlight the involvement of Dr. Barbara Schug of SocraTec R&D, who will co-chair the event, and Dr. Ralph-Steven Wedemeyer of SocraMetrics, who will lend his expertise as a member of the workshop planning committee. Join the discussions as we lay the scientific groundwork for the ICH M13 follow-on document that will set global standards for MR dosage forms.

Don’t miss your chance to be a part of GBHI 2024, April 16-17, 2024, in Rockville, Maryland, US. Read the GBHI 2022 report and register for GBHI 2024

Let’s shape the future of bioequivalence together!

GBHI 2024 Draft program 2024

All fine on single